Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000
- PMID: 17989346
- DOI: 10.1164/rccm.200701-057OC
Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000
Abstract
Rationale: The goal for tuberculosis (TB) elimination in the United States is a TB disease incidence of less than 1 per million U.S. population by 2010, which requires that the latent TB infection (LTBI) prevalence be less than 1% and decreasing.
Objectives: To estimate the prevalence of LTBI in the U.S. population.
Methods and measurements: Interviews and medical examinations, including tuberculin skin testing (TST), of 7,386 individuals were conducted in 1999-2000 as part of the National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of the civilian, noninstitutionalized U.S. population. LTBI was defined as a TST measurement of >/=10 mm. Associations of age, race/ethnicity, sex, poverty, and birthplace were assessed. Results among the 24- to 74-year-old subgroup were compared with NHANES 1971-1972 data.
Measurements and main results: Estimated LTBI prevalence was 4.2%; an estimated 11,213,000 individuals had LTBI. Among 25- to 74-year-olds, prevalence decreased from 14.3% in 1971-1972 to 5.7% in 1999-2000. Higher prevalences were seen in the foreign born (18.7%), non-Hispanic blacks/African Americans (7.0%), Mexican Americans (9.4%), and individuals living in poverty (6.1%). A total of 63% of LTBI was among the foreign born. Among the U.S. born, after adjusting for confounding factors, LTBI was associated with non-Hispanic African-American race/ethnicity, Mexican American ethnicity, and poverty. A total of 25.5% of persons with LTBI had been previously diagnosed as having LTBI or TB, and only 13.2% had been prescribed treatment.
Conclusions: In addition to basic TB control measures, elimination strategies should include targeted evaluation and treatment of individuals in high-prevalence groups, as well as enhanced support for global TB prevention and control.
Comment in
-
Decline in prevalence of latent tuberculosis infection: is the waning of tuberculin reaction a factor?Am J Respir Crit Care Med. 2008 Sep 15;178(6):651-2; author reply 652-3. doi: 10.1164/ajrccm.178.6.651a. Am J Respir Crit Care Med. 2008. PMID: 18755932 No abstract available.
-
Estimating the prevalence of tuberculosis infection in the United States population.Am J Respir Crit Care Med. 2008 Sep 15;178(6):651; author reply 652-3. doi: 10.1164/ajrccm.178.6.651. Am J Respir Crit Care Med. 2008. PMID: 18755933 No abstract available.
-
What can the NHANES data tell us about the tuberculin skin test and the risk for active tuberculosis?Am J Respir Crit Care Med. 2008 Oct 15;178(8):883-4; author reply 884. doi: 10.1164/ajrccm.178.8.883. Am J Respir Crit Care Med. 2008. PMID: 18832558 No abstract available.
Similar articles
-
Tuberculosis infection in the United States: national trends over three decades.Am J Respir Crit Care Med. 2008 Feb 15;177(4):455-60. doi: 10.1164/rccm.200706-950OC. Epub 2007 Nov 20. Am J Respir Crit Care Med. 2008. PMID: 18029790
-
Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.Am J Respir Crit Care Med. 2016 Aug 15;194(4):493-500. doi: 10.1164/rccm.201508-1560OC. Am J Respir Crit Care Med. 2016. PMID: 26890477 Free PMC article.
-
The Prevalence of Latent Tuberculosis Infection in the United States.Am J Respir Crit Care Med. 2016 Aug 15;194(4):501-9. doi: 10.1164/rccm.201508-1683OC. Am J Respir Crit Care Med. 2016. PMID: 26866439 Free PMC article.
-
[Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].Kekkaku. 2006 Nov;81(11):681-6. Kekkaku. 2006. PMID: 17154047 Review. Japanese.
-
Effectiveness of tuberculosis contact tracing among migrants and the foreign-born population.Euro Surveill. 2009 Mar 19;14(11):19153. Euro Surveill. 2009. PMID: 19317977 Review.
Cited by
-
Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.Inflamm Bowel Dis. 2013 Oct;19(11):2444-9. doi: 10.1097/MIB.0b013e31829f008f. Inflamm Bowel Dis. 2013. PMID: 23945184 Free PMC article.
-
The Association between active and passive smoking and latent tuberculosis infection in adults and children in the united states: results from NHANES.PLoS One. 2014 Mar 24;9(3):e93137. doi: 10.1371/journal.pone.0093137. eCollection 2014. PLoS One. 2014. PMID: 24664240 Free PMC article. Clinical Trial.
-
Smears and cultures for diagnosis of pulmonary tuberculosis in an asymptomatic immigrant population.Int J Gen Med. 2013 Sep 16;6:777-9. doi: 10.2147/IJGM.S48964. eCollection 2013. Int J Gen Med. 2013. PMID: 24072976 Free PMC article.
-
The latent tuberculosis infection cascade of care during the COVID-19 pandemic response in a Mid-Sized US city.J Clin Tuberc Other Mycobact Dis. 2023 May;31:100367. doi: 10.1016/j.jctube.2023.100367. Epub 2023 Apr 1. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 37034439 Free PMC article.
-
Challenges in Obtaining Estimates of the Risk of Tuberculosis Infection During Overseas Deployment.Am J Trop Med Hyg. 2015 Dec;93(6):1172-8. doi: 10.4269/ajtmh.15-0539. Epub 2015 Sep 28. Am J Trop Med Hyg. 2015. PMID: 26416114 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical